Cell Cryopreservation Market 2019 | Develop Rapidly by Top Players Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Inc., AMS Biotechnology Limited, Nippon Genetics, VitriCell SA, Miltenyi Biotec, Mediatech, Inc., BioLifeSolutions, Inc., HiMedia Labor

Launches of novel cryopreservation systems are expected to be major driver for growth of global cell cryopreservation market. For instance, in 2015, AMS Biotechnology Limited launched its new Stem-Cellbanker, a GMP grade cell cryopreservation media. Stem-Cellbanker is a freezing solution, used for preservation of stem cell, iPS cell and other cells. In 2014, Asymptote Ltd, a Cambridge-based cryopreservation specialists launched its unique range of liquid nitrogen free controlled rate freezers especially designed for the needs of regenerative medicine at the annual meeting of the International Society for Cellular Therapy (ISCT) held in Paris.

Request Sample of Report: https://www.coherentmarketinsights.com/insight/request-sample/1698

In 2013, Taiyo Nippon Sanso Corporation launched its latest CryoLibrary (CAPS-i3000), a fully-automated cryopreservation system for cryopreservation of Induced Pluripotent Stem Cell (iPS). Moreover, this field has gained significant traction from funding agencies such as venture capitals and startups, which have successfully raised funding for development of novel cell cryopreservation systems.

For instance, in January 2018, VitriCell SA, a biotech company providing innovative cryopreservation solutions closed a series A round funding of US$ 1.2 million from various investors. VitriCell SA will use this fund to launch the first products based on aseptic vitrification, a new cell cryopreservation method.

Furthermore, the approval of cryopreserved cells by regulatory bodies is also expected to increase demand for cell cryopreservation system. For instance, in 2017, U.S. Food and Drug Administration (FDA) approved ReNeuron Group Plc. cryopreserved formulation of Human Retinal Progenitor Cell (hRPC).

Key players operating in cell cryopreservation market include Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Inc., AMS Biotechnology Limited, Nippon Genetics, VitriCell SA, Miltenyi Biotec, Mediatech, Inc., BioLifeSolutions, Inc., HiMedia Laboratories, and PromoCell GmbH.

Get PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1698

Key players operating in the market are involved in strategic mergers and collaboration to expand their product portfolio and increase its product presence in key geography.

For instance, in 2013, Nippon Zenyaku Kogyo Co., Ltd and Takara Bio Inc. entered into a distribution agreement. As per the agreement Takara Bio Inc. will market Zenoaq's Cellbanker series of cell cryopreservation media exclusively in Japan and non-exclusively in Europe and North America.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.